肝细胞癌
脂肪肝
疾病
非酒精性脂肪肝
医学
代谢综合征
癌症研究
生物信息学
内科学
机制(生物学)
脂质代谢
糖尿病
内分泌学
生物
哲学
认识论
作者
Xinyue Lin,Jilei Zhang,Yajun Chu,Qiuying Nie,Junmin Zhang
标识
DOI:10.1016/j.pharmthera.2024.108593
摘要
Non-alcoholic fatty liver disease (NAFLD) is a global metabolic disease with high prevalence in both adults and children. Importantly, NAFLD is becoming the main cause of hepatocellular carcinoma (HCC). Berberine (BBR), a naturally occurring plant component, has been demonstrated to have advantageous effects on a number of metabolic pathways as well as the ability to kill liver tumor cells by causing cell death and other routes. This permits us to speculate and make assumptions about the value of BBR in the prevention and defense against NAFLD and HCC by a global modulation of metabolic disorders. Herein, we briefly describe the etiology of NAFLD and NAFLD-related HCC, with a particular emphasis on analyzing the potential mechanisms of BBR in the treatment of NAFLD from aspects including increasing insulin sensitivity, controlling the intestinal milieu, and controlling lipid metabolism. We also elucidate the mechanism of BBR in the treatment of HCC. More significantly, we provided a list of clinical studies for BBR in NAFLD. Taking into account our conclusions and perspectives, we can make further progress in the treatment of BBR in NAFLD and NAFLD-related HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI